NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | ![](/images/7308/19162_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
OSBPL7 | Oxysterol binding protein-like 7 | | ![](/images/36076/ihc_selected_60x60.jpg) | ![](/images/53083/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36076/69742_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PIK3C2G | Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma | Enzymes Plasma proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PLA2G10 | Phospholipase A2, group X | Enzymes Predicted secreted proteins RAS pathway related proteins
| ![](/images/41893/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41893/90311_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PSCA | Prostate stem cell antigen | Cancer-related genes Predicted membrane proteins
| ![](/images/56418/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56418/132824_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
PTGDR2 | Prostaglandin D2 receptor 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/14259/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/14259/ihc_cell_selected_60x60.jpg) | ![](/images/14259/39385_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
RAB27B | RAB27B, member RAS oncogene family | Plasma proteins
| | ![](/images/19849/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17712/39127_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
RASEF | RAS and EF-hand domain containing | | | ![](/images/21431/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21431/49176_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
RASSF6 | Ras association (RalGDS/AF-6) domain family member 6 | | ![](/images/37711/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37711/82671_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
RFX6 | Regulatory factor X, 6 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37696/81148_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
RNF223 | Ring finger protein 223 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
S100P | S100 calcium binding protein P | Plasma proteins
| ![](/images/19502/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19502/46826_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins
| | | ![](/images/6641/ihc_cell_selected_60x60.jpg) | ![](/images/6641/142549_B_4_6_rna_selected_60x60.jpg) | Tissue enhanced |
SHH | Sonic hedgehog | Disease related genes Predicted secreted proteins
| ![](/images/18966/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18966/42048_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
SLC26A9 | Solute carrier family 26 (anion exchanger), member 9 | Predicted membrane proteins Transporters
| ![](/images/51485/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/51485/ihc_cell_selected_60x60.jpg) | ![](/images/51485/119484_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
SLC9A2 | Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | Plasma proteins Predicted membrane proteins Transporters
| ![](/images/35121/ihc_selected_60x60.jpg) | ![](/images/35121/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35121/69774_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
SMIM6 | Small integral membrane protein 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65721/147243_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
SOSTDC1 | Sclerostin domain containing 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SOX21 | SRY (sex determining region Y)-box 21 | Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SPTSSB | Serine palmitoyltransferase, small subunit B | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
SSTR1 | Somatostatin receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31506/140928_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
SULT1C2 | Sulfotransferase family, cytosolic, 1C, member 2 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/7190/ihc_cell_selected_60x60.jpg) | ![](/images/7190/20291_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SYTL5 | Synaptotagmin-like 5 | Plasma proteins
| ![](/images/26074/ihc_selected_60x60.jpg) | ![](/images/26074/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26074/56918_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | ![](/images/42037/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40810/89935_B_3_6_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM211 | Transmembrane protein 211 | Predicted membrane proteins
| ![](/images/66784/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66784/149801_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM238 | Transmembrane protein 238 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
TMPRSS3 | Transmembrane protease, serine 3 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| ![](/images/31305/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31305/69407_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
TPSD1 | Tryptase delta 1 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2215/5880_B_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
TRIM50 | Tripartite motif containing 50 | | ![](/images/19862/ihc_selected_60x60.jpg) | ![](/images/19862/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19862/46716_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
TRIM74 | Tripartite motif containing 74 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
TRNP1 | TMF1-regulated nuclear protein 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
UNC5CL | Unc-5 homolog C (C. elegans)-like | | ![](/images/15725/ihc_selected_60x60.jpg) | ![](/images/15725/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15725/35749_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
UPK1B | Uroplakin 1B | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31799/68902_A_6_3_rna_selected_60x60.jpg) | Tissue enhanced |
VILL | Villin-like | Plasma proteins
| | ![](/images/35676/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35675/77460_B_5_7_rna_selected_60x60.jpg) | Tissue enhanced |
VSIG2 | V-set and immunoglobulin domain containing 2 | Predicted membrane proteins
| ![](/images/35919/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35919/76802_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
VWA2 | Von Willebrand factor A domain containing 2 | Predicted secreted proteins
| ![](/images/37847/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37847/78932_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
ZFPM1 | Zinc finger protein, FOG family member 1 | Plasma proteins Transcription factors
| ![](/images/46603/ihc_selected_60x60.jpg) | ![](/images/46603/if_selected_60x60.jpg) | ![](/images/46603/ihc_cell_selected_60x60.jpg) | ![](/images/46603/117426_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |